Trial intelligence / Profile preview

Bivalirudin vs Heparin in Pediatric ECMO

NCT03318393Phase 4Completed

Sponsor
UT Southwestern Medical Center
Start
Mar 2018
Primary completion
Oct 2021
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bivalirudin in thrombosis, sponsored by UT Southwestern Medical Center. Started Mar 2018; status: completed.

02

Drugs

bivalirudin
03

Conditions

thrombosis

Beyond the preview

Go deeper on NCT03318393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03318393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call